China Dasheng Biotechnology (CDBT) Short Interest Ratio & Short Volume

Short interest is the volume of China Dasheng Biotechnology shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 100 shares of CDBT short. Learn More on China Dasheng Biotechnology's current short interest.

Here is how the short interest of companies in the industry of "retail" compare to China Dasheng Biotechnology: Kaival Brands Innovations Group, Inc. (1.04%).

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

Short selling CDBT is an investing strategy that aims to generate trading profit from China Dasheng Biotechnology as its price is falling. CDBT shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for China Dasheng Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CDBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDBT, twice per month. The most recent reporting period available is November, 30 2024.